{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T13:42:43Z","timestamp":1779370963212,"version":"3.53.0"},"reference-count":51,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejso.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Surgical Oncology"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1016\/j.ejso.2018.12.019","type":"journal-article","created":{"date-parts":[[2018,12,25]],"date-time":"2018-12-25T01:19:31Z","timestamp":1545700771000},"page":"1132-1137","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"title":["Prognostic and clinical significance of syndecan-1 expression in breast cancer: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"45","author":[{"given":"Weiqiang","family":"Qiao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heyang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanying","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miao","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejso.2018.12.019_bib1","first-page":"7","article-title":"Cancer statistics","volume":"68","author":"Siegel","year":"2018","journal-title":"Ca - Cancer J Clin"},{"key":"10.1016\/j.ejso.2018.12.019_bib2","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1093\/annonc\/mdv221","article-title":"Tailoring therapies--improving the management of early breast cancer: St gallen international expert consensus on the primary therapy of early breast cancer 2015","volume":"26","author":"Coates","year":"2015","journal-title":"Ann oncol"},{"key":"10.1016\/j.ejso.2018.12.019_bib3","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.breast.2016.07.016","article-title":"The St. Gallen surrogate classification for breast cancer subtypes successfully predicts tumor presenting features, nodal involvement, recurrence patterns and disease free survival","volume":"29","author":"Vasconcelos","year":"2016","journal-title":"Breast"},{"key":"10.1016\/j.ejso.2018.12.019_bib4","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s13058-017-0827-4","article-title":"Overexpression of syndecan-1, MUC-1, and putative stem cell markers in breast cancer leptomeningeal metastasis: a cerebrospinal fluid flow cytometry study","volume":"19","author":"Cordone","year":"2017","journal-title":"Breast Cancer Res"},{"key":"10.1016\/j.ejso.2018.12.019_bib5","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.urolonc.2018.03.010","article-title":"Circulating syndecan-1 is associated with chemotherapy-resistance in castration-resistant prostate cancer","volume":"36","author":"Szarvas","year":"2018","journal-title":"Urol Oncol"},{"key":"10.1016\/j.ejso.2018.12.019_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.critrevonc.2014.12.003","article-title":"Advances in the molecular functions of syndecan-1 (SDC1\/CD138) in the pathogenesis of malignancies","volume":"94","author":"Gharbaran","year":"2015","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.ejso.2018.12.019_bib7","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.oooo.2015.11.015","article-title":"Immunohistochemical expression of K6, K8, K16, K17, K19, maspin, syndecan-1 (CD138), alpha-SMA, and Ki-67 in ameloblastoma and ameloblastic carcinoma: diagnostic and prognostic correlations","volume":"121","author":"Safadi","year":"2016","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"key":"10.1016\/j.ejso.2018.12.019_bib8","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s12943-017-0621-z","article-title":"Syndecan-1 is a novel molecular marker for triple negative inflammatory breast cancer and modulates the cancer stem cell phenotype via the IL-6\/STAT3, Notch and EGFR signaling pathways","volume":"16","author":"Ibrahim","year":"2017","journal-title":"Mol cancer"},{"key":"10.1016\/j.ejso.2018.12.019_bib9","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1007\/s11095-018-2400-y","article-title":"Activity of indatuximab ravtansine against triple-negative breast cancer in preclinical tumor models","volume":"35","author":"Schonfeld","year":"2018","journal-title":"Pharm Res (N Y)"},{"key":"10.1016\/j.ejso.2018.12.019_bib10","article-title":"Sphingosine 1-phosphate regulates proliferation, cell cycle and apoptosis of hepatocellular carcinoma cells via syndecan-1","author":"Zeng","year":"2017","journal-title":"Prog Biophys Mol Biol"},{"key":"10.1016\/j.ejso.2018.12.019_bib11","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1002\/ijc.30367","article-title":"Prognostic value of baseline seric Syndecan-1 in initially unresectable metastatic colorectal cancer patients: a simple biological score","volume":"139","author":"Jary","year":"2016","journal-title":"Int J Canc"},{"key":"10.1016\/j.ejso.2018.12.019_bib12","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1111\/j.1600-0463.2010.02609.x","article-title":"The prognostic value of intraepithelial and stromal CD3-, CD117- and CD138-positive cells in non-small cell lung carcinoma","volume":"118","author":"Al-Shibli","year":"2010","journal-title":"Apmis"},{"key":"10.1016\/j.ejso.2018.12.019_bib13","first-page":"917","article-title":"Clinical significance of syndecan-1 and versican expression in human epithelial ovarian cancer","volume":"23","author":"Kusumoto","year":"2010","journal-title":"Oncol rep"},{"key":"10.1016\/j.ejso.2018.12.019_bib14","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1111\/j.1464-410X.2009.09099.x","article-title":"Syndecan-1 expression in prostate cancer and its value as biomarker for disease progression","volume":"106","author":"Brimo","year":"2010","journal-title":"BJU Int"},{"key":"10.1016\/j.ejso.2018.12.019_bib15","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s00534-009-0046-1","article-title":"Fascin overexpression correlates with positive thrombospondin-1 and syndecan-1 expressions and a more aggressive clinical course in patients with gallbladder cancer","volume":"16","author":"Roh","year":"2009","journal-title":"J\u00a0Hepatobiliary Pancreat Surg"},{"key":"10.1016\/j.ejso.2018.12.019_bib16","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.3748\/wjg.14.1990","article-title":"Relationship between cell adhesion molecules expression and the biological behavior of gastric carcinoma","volume":"14","author":"Chu","year":"2008","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.ejso.2018.12.019_bib17","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s10549-005-9135-2","article-title":"Syndecan-1 and syndecan-4 are overexpressed in an estrogen receptor-negative, highly proliferative breast carcinoma subtype","volume":"98","author":"Baba","year":"2006","journal-title":"Breast Canc Res Treat"},{"key":"10.1016\/j.ejso.2018.12.019_bib18","first-page":"474","article-title":"High syndecan-1 expression in breast carcinoma is related to an aggressive phenotype and to poorer prognosis","volume":"98","author":"Barbareschi","year":"2003","journal-title":"Cancer-Am cancer soc"},{"key":"10.1016\/j.ejso.2018.12.019_bib19","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1158\/1055-9965.EPI-17-0720","article-title":"Collagen alignment as a predictor of recurrence after ductal carcinoma in situ","volume":"27","author":"Conklin","year":"2018","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"10.1016\/j.ejso.2018.12.019_bib20","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1038\/sj.bjc.6604400","article-title":"Prognostic impact of syndecan-1 expression in invasive ductal breast carcinomas","volume":"98","author":"Loussouarn","year":"2008","journal-title":"Br J Canc"},{"key":"10.1016\/j.ejso.2018.12.019_bib21","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s10654-010-9491-z","article-title":"Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses","volume":"25","author":"Stang","year":"2010","journal-title":"Eur J Epidemiol"},{"key":"10.1016\/j.ejso.2018.12.019_bib22","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.ijsu.2010.02.007","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"8","author":"Moher","year":"2010","journal-title":"Int J Surg"},{"key":"10.1016\/j.ejso.2018.12.019_bib23","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1745-6215-8-16","article-title":"Practical methods for incorporating summary time-to-event data into meta-analysis","volume":"8","author":"Tierney","year":"2007","journal-title":"Trials"},{"key":"10.1016\/j.ejso.2018.12.019_bib24","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1016\/j.ejso.2018.12.019_bib25","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.cct.2015.09.002","article-title":"Meta-analysis in clinical trials revisited","volume":"45","author":"DerSimonian","year":"2015","journal-title":"Contemp Clin Trials"},{"key":"10.1016\/j.ejso.2018.12.019_bib26","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.2307\/2533446","article-title":"Operating characteristics of a rank correlation test for publication bias","volume":"50","author":"Begg","year":"1994","journal-title":"Biometrics"},{"key":"10.1016\/j.ejso.2018.12.019_bib27","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"key":"10.1016\/j.ejso.2018.12.019_bib28","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.jclinepi.2007.03.013","article-title":"Trial sequential analysis may establish when firm evidence is reached in cumulative meta-analysis","volume":"61","author":"Wetterslev","year":"2008","journal-title":"J\u00a0Clin epidemiol"},{"key":"10.1016\/j.ejso.2018.12.019_bib29","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1093\/jnci\/djh075","article-title":"Assessing the probability that a positive report is false: an approach for molecular epidemiology studies","volume":"96","author":"Wacholder","year":"2004","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.ejso.2018.12.019_bib30","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1186\/1477-7819-11-314","article-title":"Prognostic significance of RSPO1, WNT1, P16, WT1, and SDC1 expressions in invasive ductal carcinoma of the breast","volume":"11","author":"Choi","year":"2013","journal-title":"World J Surg oncol"},{"key":"10.1016\/j.ejso.2018.12.019_bib31","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1159\/000080280","article-title":"Prognostic value of syndecan-1 expression in breast cancer","volume":"67","author":"Leivonen","year":"2004","journal-title":"Oncology-basel"},{"key":"10.1016\/j.ejso.2018.12.019_bib32","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1369\/0022155411405057","article-title":"Syndecan-1 and syndecan-4 are independent indicators in breast carcinoma","volume":"59","author":"Lendorf","year":"2011","journal-title":"J\u00a0Histochem cytochem"},{"key":"10.1016\/j.ejso.2018.12.019_bib33","doi-asserted-by":"crossref","first-page":"468","DOI":"10.11622\/smedj.2014115","article-title":"Syndecan-1 is a potential biomarker for triple-positive breast carcinomas in Asian women with correlation to survival","volume":"55","author":"Lim","year":"2014","journal-title":"Singapore Med J"},{"key":"10.1016\/j.ejso.2018.12.019_bib34","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1309\/AJCPZ1D8CALHDXCJ","article-title":"Syndecan-1 overexpression is associated with nonluminal subtypes and poor prognosis in advanced breast cancer","volume":"140","author":"Nguyen","year":"2013","journal-title":"Am J Clin pathol"},{"key":"10.1016\/j.ejso.2018.12.019_bib35","first-page":"3607","article-title":"Significance of syndecan-1 expression in ductal carcinoma in situ of the breast","volume":"34","author":"Tiemann","year":"2014","journal-title":"Anticancer Res"},{"key":"10.1016\/j.ejso.2018.12.019_bib36","doi-asserted-by":"crossref","first-page":"111444","DOI":"10.18632\/oncotarget.22820","article-title":"Clinicopathological and prognostic significance of SDC1 overexpression in breast cancer","volume":"8","author":"Cui","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.ejso.2018.12.019_bib37","doi-asserted-by":"crossref","first-page":"40922","DOI":"10.18632\/oncotarget.16733","article-title":"Syndecan-1 knockdown inhibits glioma cell proliferation and invasion by deregulating a c-src\/FAK-associated signaling pathway","volume":"8","author":"Shi","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.ejso.2018.12.019_bib38","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1002\/pros.23186","article-title":"Soluble syndecan-1 (SDC1) serum level as an independent pre-operative predictor of cancer-specific survival in prostate cancer","volume":"76","author":"Szarvas","year":"2016","journal-title":"Prostate"},{"key":"10.1016\/j.ejso.2018.12.019_bib39","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1593\/neo.10586","article-title":"Syndecan-1-dependent suppression of PDK1\/Akt\/bad signaling by docosahexaenoic acid induces apoptosis in prostate cancer","volume":"12","author":"Hu","year":"2010","journal-title":"Neoplasia"},{"key":"10.1016\/j.ejso.2018.12.019_bib40","doi-asserted-by":"crossref","first-page":"4981","DOI":"10.1158\/0008-5472.CAN-16-0232","article-title":"Syndecan-1 (CD138) Suppresses apoptosis in multiple myeloma by activating IGF1 receptor: prevention by SynstatinIGF1R inhibits tumor growth","volume":"76","author":"Beauvais","year":"2016","journal-title":"Cancer Res"},{"key":"10.1016\/j.ejso.2018.12.019_bib41","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/j.humpath.2013.10.036","article-title":"Enhanced stromal syndecan-1 expression is an independent risk factor for poor survival in bladder cancer","volume":"45","author":"Szarvas","year":"2014","journal-title":"Hum pathol"},{"key":"10.1016\/j.ejso.2018.12.019_bib42","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/j.ajpath.2017.12.009","article-title":"Syndecan-1 controls lung tumorigenesis by regulating miRNAs packaged in exosomes","volume":"188","author":"Parimon","year":"2018","journal-title":"Am J Pathol"},{"key":"10.1016\/j.ejso.2018.12.019_bib43","doi-asserted-by":"crossref","first-page":"161","DOI":"10.3802\/jgo.2011.22.3.161","article-title":"Prognostic significance of syndecan-1 expression in cervical cancers","volume":"22","author":"Kim","year":"2011","journal-title":"J.\u00a0Gynecol Oncol"},{"key":"10.1016\/j.ejso.2018.12.019_bib44","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1186\/s12876-015-0383-2","article-title":"Prognostic and clinical significance of syndecan-1 in colorectal cancer: a meta-analysis","volume":"15","author":"Wei","year":"2015","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.ejso.2018.12.019_bib45","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1007\/s12282-017-0773-0","article-title":"Elevated Syndecan-1 levels in the sera of patients with breast cancer correlate with tumor size","volume":"24","author":"Malek-Hosseini","year":"2017","journal-title":"Breast Cancer-tokyo"},{"key":"10.1016\/j.ejso.2018.12.019_bib46","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1080\/0284186X.2016.1237778","article-title":"Histological grade provides significant prognostic information in addition to breast cancer subtypes defined according to St Gallen 2013","volume":"56","author":"Ehinger","year":"2017","journal-title":"Acta Oncol"},{"key":"10.1016\/j.ejso.2018.12.019_bib47","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.breast.2017.05.005","article-title":"Follow-up of patients with localized breast cancer and first indicators of advanced breast cancer recurrence: a retrospective study","volume":"34","author":"Viot","year":"2017","journal-title":"Breast"},{"key":"10.1016\/j.ejso.2018.12.019_bib48","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.clbc.2016.06.012","article-title":"Prognostic significance of progesterone receptor expression in estrogen-receptor positive, HER2-negative, node-negative invasive breast cancer with a low ki-67 labeling index","volume":"17","author":"Ono","year":"2017","journal-title":"Clin Breast cancer"},{"key":"10.1016\/j.ejso.2018.12.019_bib49","first-page":"621","article-title":"Predictive value of syndecan-1 expression for the response to neoadjuvant chemotherapy of primary breast cancer","volume":"26","author":"Gotte","year":"2006","journal-title":"Anticancer Res"},{"key":"10.1016\/j.ejso.2018.12.019_bib50","doi-asserted-by":"crossref","first-page":"2825","DOI":"10.3892\/ol.2015.3072","article-title":"Effect of neoadjuvant chemotherapy in patients with triple-negative breast cancer: a meta-analysis","volume":"9","author":"Tian","year":"2015","journal-title":"Oncol lett"},{"key":"10.1016\/j.ejso.2018.12.019_bib51","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1001\/jamaoncol.2015.6113","article-title":"Association of pathologic complete response to neoadjuvant therapy in HER2-positive breast cancer with long-term outcomes: a meta-analysis","volume":"2","author":"Broglio","year":"2016","journal-title":"Jama oncol"}],"container-title":["European Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798318320419?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798318320419?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T01:29:38Z","timestamp":1760059778000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0748798318320419"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":51,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2019,7]]}},"alternative-id":["S0748798318320419"],"URL":"https:\/\/doi.org\/10.1016\/j.ejso.2018.12.019","relation":{},"ISSN":["0748-7983"],"issn-type":[{"value":"0748-7983","type":"print"}],"subject":[],"published":{"date-parts":[[2019,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prognostic and clinical significance of syndecan-1 expression in breast cancer: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"European Journal of Surgical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejso.2018.12.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd, BASO ~ The Association for Cancer Surgery, and the European Society of Surgical Oncology. All rights reserved.","name":"copyright","label":"Copyright"}]}}